Physician profile
Matthew E Mosbacker
NPI 1558330530
$10,811.47
in general payments reported to CMS, 2019-2025
35 companies · $1,614 in 2025
The $1,614 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,742 · 2020: $1,452 · 2021: $1,390 · 2022: $1,319 · 2023: $1,707 · 2024: $1,588 · 2025: $1,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,903 · Education: $5.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,903.40 |
| Education | $5.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,506.07 | 2019-2025 | |
| Amgen INC. | $1,339.68 | 2019-2025 | Enbrel, Krystexxa, Otezla |
| Novartis Pharmaceuticals Corporation | $1,337.69 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $905.11 | 2019-2023 | Orencia |
| Glaxosmithkline, LLC. | $752.50 | 2019-2025 | Benlysta |
| Janssen Biotech, INC. | $689.78 | 2019-2025 | Tremfya, Simponi Aria |
| Ucb, INC. | $610.59 | 2019-2025 | Cimzia, Bimzelx |
| Aurinia Pharma U.S., INC. | $514.27 | 2022-2025 | Lupkynis |
| Horizon Therapeutics Plc | $340.51 | 2019-2023 | Krystexxa |
| Lilly USA, LLC | $303.92 | 2019-2024 | Taltz |
| Astrazeneca Pharmaceuticals Lp | $230.64 | 2023-2025 | Saphnelo |
| Genzyme Corporation | $214.14 | 2019-2022 | |
| Genentech USA, INC. | $197.20 | 2019-2021 | |
| Pfizer INC. | $168.72 | 2019-2023 | |
| Cardinal Health 108 LLC | $135.10 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $89.19 | 2021-2024 | Senza |
| Sanofi-Aventis U.S. LLC | $61.85 | 2019-2020 | |
| Radius Health, INC. | $44.43 | 2019-2023 | Tymlos |
| Medtronic, INC. | $37.41 | 2025 | Stealthstation S8 Platform |
| Octapharma USA, INC. | $35.00 | 2023-2024 | Octagam Immune Globulin (Human) |
| Tersera Therapeutics LLC | $33.58 | 2023 | Quzyttir |
| Fresenius Kabi USA, LLC | $31.68 | 2023-2024 | Idacio |
| Sobi, INC | $28.84 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.02 | 2022-2025 | |
| Almatica Pharma LLC | $22.99 | 2025 | Teriparatide |
| Grifols USA, LLC | $19.37 | 2025 | Gamunex-C |
| Depuy Synthes Sales INC. | $16.96 | 2019 | |
| Abbott Laboratories | $16.85 | 2019 | |
| Antares Pharma, INC. | $15.82 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $14.82 | 2022 | |
| Ani Pharmaceuticals, INC. | $14.43 | 2024 | Purified Cortrophin Gel |
| Mylan Institutional INC. | $14.19 | 2023 | |
| Organon LLC | $14.04 | 2025 | Hadlima |
| Teva Pharmaceuticals USA, INC. | $14.04 | 2023 | Truxima |
| Kiniksa Pharmaceuticals, Ltd. | $13.04 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mosbacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.